Preparing for the Potential Rollout of New Alzheimer's Drugs: Towards a Policy, Research, and Innovation Agenda
Several promising new drugs appear to slow cognitive decline in individuals with early-stage Alzheimer's disease. A number of challenges need to be addressed to ensure their successful rollout, but there are also opportunities for health innovation.